Effectiveness of a six‐drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children

Fourteen children with mediastinal lymphoblastic lymphoma (MLL) were treated with the six‐drug APO protocol. This regimen includes aggressive intermittent chemotherapy and prophylactic central nervous system therapy. Mediastinal irradiation was given only for emergency relief of mediastinal compression (two children) or for incomplete resolution of mediastinal widening with chemotherapy (one child). All 14 patients achieved complete remission; only 1 has relapsed. Toxicities were not severe. APO is effective therapy for children with MLL. APO should receive further trials in children and adults with T‐cell lymphoblastic lymphomas.

[1]  J. Pullen,et al.  Pediatric oncology group experience with modified LSA2‐L2 therapy in 107 children with non‐Hodgkin's lymphoma (Burkitt's lymphoma excluded) , 1985, Cancer.

[2]  J. Cassady,et al.  Long-term results of the APO protocol (vincristine, doxorubicin [adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  James R. Anderson,et al.  Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). , 1983, The New England journal of medicine.

[4]  A. Paganini-Hill,et al.  Successful therapy of convoluted T-lymphoblastic lymphoma in the adult. , 1983, Blood.

[5]  A. Bernard,et al.  Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor , 1982 .

[6]  B. Camitta,et al.  Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapse. , 1982, Leukemia research.

[7]  B. Nathwani,et al.  Lymphoblastic lymphoma: A clinicopathologic study of 95 patients , 1981, Cancer.

[8]  J. Dausset,et al.  Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma , 1981 .

[9]  S. Rosenberg,et al.  Lymphoblastic lymphoma in adults: results of a pilot protocol. , 1981, Blood.

[10]  S. Jones,et al.  The chemotherapy of lymphoblastic lymphoma. , 1981, Blood.

[11]  S B Murphy,et al.  A randomized trial of combined modality therapy of childhood non‐Hodgkin's lymphoma , 1980, Cancer.

[12]  N. Wollner,et al.  Non‐Hodgkin's lymphoma in children. A progress report on the original patients treated with the LSA2‐L2 protocol , 1979, Cancer.

[13]  N. Jaffe,et al.  Improved prognosis for patients with mediastinal lymphoblastic lymphoma. , 1979, Blood.

[14]  S. Sallan,et al.  Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results. , 1978, Blood.

[15]  B N Nathwani,et al.  Malignant lymphoma, lymphoblastic , 1976, Cancer.

[16]  B. Mills,et al.  Erythrocyte receptors and thymus-associated antigens on human thymocytes, mitogen-induced blasts, and acute leukemia blasts. , 1976, Cancer research.

[17]  R. Mastrangelo,et al.  Childhood lymphoblastic lymphoma, a cancer of thymus-derived lymphocytes. , 1974, Cancer research.

[18]  M. Sullivan,et al.  Undifferentiated lymphoma, non-Burkitt's type. Meningeal and bone marrow involvement in children. , 1973, American journal of diseases of children.

[19]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .